A recent report demonstrated that constitutive STAT3 activation can be mediated via the IL-6/gp130/JAK autocrine signaling pathway in different thyroid cancer lines that express RET/PTC, B-RafV600E, or mutated Ras [90]. This evidence concerns the gene RET and thyroid gland carcinoma.